Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 February 2019 | Story Ruan Bruwer
Tharina van der Walt
The hammer thrower Tharina van der Walt is one of several first-class athletes among the first-year students at Kovsies this year. She is the South African U18 champ and record-holder in 2018.

Several top athletes, some of whom were the very best in the country in their respective events at school, have joined Kovsies as first-year students. They already had their first taste of glory as Kovsies when they recently won their events at the first-year meeting.
 
Among these first-years are Jannes Schlebusch (javelin thrower), Joviale Mbisha (sprinter), Colette Uys (discus/shot-put), and Tharina van der Walt (hammer thrower), who have all represented South Africa in the past two years.
 
Schlebusch won the silver medal at the World U18 championships in 2017, but was injured last year. Great things were expected for 2019, but during the first-year meeting he injured his ankle to such an extent that he will have to undergo an operation that would put him on the sideline for the rest of the season.
 
Van der Walt was the South African schools champ in the hammer throw for girls U19 in 2018, when she managed to set up a new school record of 57,83 m. She was ranked fourth at the World U18 champs in 2017. At the same meeting, Mbisha ended 14th in the 100 m.
 
Uys, who participated in the CAA Southern Region Youth and Junior Championships last year, achieved a second place in the discus at the 2018 National Secondary Schools Championships for girls U19. Other first-years who took part in the SA’s last year, are Vicky Oelofse (1 500 m) and Michael Skosana (long jump).
 
They will strengthen Kovsie Athletics, which already boasts a large group of athletes with international experience. Of the 16 athletes who participated internationally last year, only Kesa Molotsane and Lara Orrock will not be in action for the students again.
 
■ Imperium Residence won the men’s division and Arista/Amelia were the ladies’ winners.
 

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept